1. Home
  2. IQV vs CLS Comparison

IQV vs CLS Comparison

Compare IQV & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$273.59

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Logo Celestica Inc.

CLS

Celestica Inc.

HOLD

Current Price

$250.98

Market Cap

41.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
CLS
Founded
1982
1994
Country
United States
Canada
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
43.1B
41.9B
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
IQV
CLS
Price
$273.59
$250.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
22
Target Price
$302.67
★ $471.14
AVG Volume (30 Days)
1.0M
★ 1.9M
Earning Date
10-27-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
4.67
★ 98.34
EPS
1.61
★ 5.01
Revenue
$9,739,000,000.00
★ $12,390,900,000.00
Revenue This Year
$6.79
$66.31
Revenue Next Year
$6.06
$73.28
P/E Ratio
$172.91
★ $51.82
Revenue Growth
★ 41.60
28.46
52 Week Low
$154.50
$249.02
52 Week High
$282.98
$474.03

Technical Indicators

Market Signals
Indicator
IQV
CLS
Relative Strength Index (RSI) 57.47 28.16
Support Level $252.55 N/A
Resistance Level $274.49 $316.65
Average True Range (ATR) 7.84 19.68
MACD 1.06 -10.99
Stochastic Oscillator 67.59 4.45

Price Performance

Historical Comparison
IQV
CLS

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About CLS Celestica Inc.

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Share on Social Networks: